Haim–Munk syndrome

From WikiMD's WELLNESSPEDIA

(Redirected from Cochin Jewish disorder)


Haim–Munk syndrome
Synonyms Cochin Jewish disorder
Pronounce N/A
Specialty N/A
Symptoms Palmoplantar keratoderma, periodontitis, onychogryphosis, acral osteolysis
Complications Tooth loss, bone resorption
Onset Childhood
Duration Lifelong
Types
Causes Genetic mutation in the CTSC gene
Risks
Diagnosis Genetic testing, clinical examination
Differential diagnosis Papillon–Lefèvre syndrome, Mal de Meleda
Prevention
Treatment Retinoids, antibiotics, dental care
Medication
Prognosis Variable, depends on management of symptoms
Frequency Rare
Deaths


Haim–Munk syndrome (HMS) is a rare autosomal recessive genetic disorder characterized by a combination of palmoplantar keratoderma, periodontitis, onychogryphosis, and acral osteolysis. It is named after the physicians Seymour Haim and J. Munk, who first described the condition.

Clinical Features[edit]

Haim–Munk syndrome presents with several distinctive clinical features:

  • Palmoplantar keratoderma: Thickening of the skin on the palms of the hands and the soles of the feet.
  • Periodontitis: Severe inflammation of the gums leading to early loss of teeth.
  • Onychogryphosis: Abnormal curvature and thickening of the nails.
  • Acral osteolysis: Bone resorption in the distal phalanges, leading to shortening of the fingers and toes.

Genetics[edit]

Haim–Munk syndrome is inherited in an autosomal recessive manner. The condition is caused by mutations in the CTSC gene, which encodes the enzyme cathepsin C. This enzyme is crucial for the activation of certain proteases involved in the immune response and skin integrity.

Diagnosis[edit]

Diagnosis of Haim–Munk syndrome is based on clinical evaluation, family history, and genetic testing to identify mutations in the CTSC gene. Differential diagnosis includes other conditions with similar features, such as Papillon–Lefèvre syndrome.

Treatment[edit]

There is no cure for Haim–Munk syndrome. Treatment focuses on managing symptoms and may include:

Prognosis[edit]

The prognosis for individuals with Haim–Munk syndrome varies. Early diagnosis and management of symptoms can improve the quality of life, but the condition can lead to significant morbidity due to dental issues and skin problems.

Related Pages[edit]

See Also[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.